Announcements Trials

Browse Landscape

Phase

Status

Recruiting 1 Completed 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Breast Neoplasms 1

Interventions

pembrolizumab 68 Cyclophosphamide 46 Cisplatin 43 Nivolumab 36 Paclitaxel 33 Carboplatin 31 Radiotherapy 29 Gemcitabine 28 Docetaxel 25 Dexamethasone 22 atezolizumab 21 Bevacizumab 20 Doxorubicin 19 Magnetic Resonance Spectroscopy 18 Blood Specimen Collection 18 Radiosurgery 17 fludarabine 16 Vincristine 16 Lenalidomide 16 Etoposide 16 Letrozole 15 Ipilimumab 15 Fluorouracil 15 palbociclib 14 Surveys and Questionnaires 14 Rituximab 14 Radiation 14 Leucovorin 14 Cytarabine 14 durvalumab 13

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Autogenic Training × 90 days × Clear all

NCT07023822 2026-05-05

WISH, Feasibility of a Factorial Design

The University of Tennessee, Knoxville

Phase NA Completed

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡